Table 1.
ID | Reference | Technology (measurements) | Missing |
---|---|---|---|
CAUS | Causton et al. (2001) | commercial microarray (×5) | 19–22% |
DUD | Dudley et al. (2002) | custom microarray (×4) | 5% |
GARC | García-Martínez et al. (2004) | custom microarray | 1% |
HOLS | Holstege et al. (1998) | commercial microarray | 12% |
ING1 | Ingolia et al. (2009) | RNA-Seq (mRNA rich) (×2) | 9–10% |
ING2 | Ingolia lab, unpublished, 2010 | RNA-Seq (rq) (×2) | 4–5% |
ING3 | Ingolia lab, unpublished, 2010 | RNA-Seq (ca) (×2) | 6–8% |
LIP1 | Lipson et al. (2009) | RNA-Seq (×6) | 1% |
LIP2 | Lipson et al. (2009) | commercial microarray | 4% |
MAC | MacKay et al. (2004) | custom microarray | 28% |
MIUR | Miura et al. (2008) | cPCR (×4) | 26–29% |
NGAL | Nagalakshmi et al. (2008) | RNA-Seq | 22% |
PELE | Pelechano and Pérez-Ortín (2010) | custom microarray | 14% |
ROTH | Roth et al. (1998) | commercial microarray (×2) | 59–70% |
VELC | Velculescu et al. (1997) | SAGE | 58% |
YASS | Yassour et al. (2009) | RNA-Seq (×4) | 5% |
FUTR | Futcher et al. (1999) | 2D gel | 99% |
GHAM | Ghaemmaghami et al. (2003) | Western blot | 34% |
GODO | de Godoy et al. (2008) | LC MS/MS | 25% |
GYGI | Gygi et al. (1999) | 2D gel | 98% |
LEE | Lee et al. (2011) | LC MS/MS (×3) | 67–76% |
LU | Lu et al. (2007) | LC MS/MS | 83% |
NGAR | Nagaraj et al. (2012) | LC MS/MS (×6) | 31% |
NEWM | Newman et al. (2006) | GFP | 60% |
PENG | Peng et al. (2003) | LC MS/MS | 74% |
THAK | Thakur et al. (2011) | LC MS/MS (×3) | 84–85% |
WASH | Washburn et al. (2001) | LC MS/MS | 77% |